Regulation of LYRM1 gene expression by free fatty acids, adipokines, and rosiglitazone in 3T3-L1 adipocytes

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Zhang, Min ^a   Zhao, Hai Ming ^b   Qin, Zhen Ying ^c   Qin, Rui ^a   Chen, Xiao Hui ^a   Zhao, Ya Ping ^c   Zhang, Chun Mei ^a   Gao, Chun Lin ^c   Zhu, Chun ^a   Ji, Chen Bo ^a   Cao, Xin Guo ^a   Guo, Xi Rong ^c  

^a WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MESSENGER RNA; RESISTIN; ROSIGLITAZONE; SRP 4560; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; APOPTOSIS REGULATORY PROTEIN; LYR MOTIF CONTAINING 1 PROTEIN, MOUSE;

ADIPOCYTE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LYR MOTIF CONTAINING 1 GENE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MOUSE;

3T3-L1 CELLS; ADIPOKINES; ANIMALS; APOPTOSIS REGULATORY PROTEINS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; MICE; RESISTIN; RNA, MESSENGER; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855183085     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/820989     Document Type: Article

References (36)

1. Jeffery R. W., Sherwood N. E., Is the obesity epidemic exaggerated? No BMJ 2008 336 7638 245
2. Stumvoll M., Goldstein B. J., van Haeften T. W., Type 2 diabetes: pathogenesis and treatment The Lancet 2008 371 9631 2153 2156 (Pubitemid 351885026)
3. Zimmet P., Alberti K. G. M., Shaw J., Global and societal implications of the diabetes epidemic Nature 2001 414 6865 782 787 (Pubitemid 34000780)
4. Walley A. J., Asher J. E., Froguel P., The genetic contribution to non-syndromic human obesity Nature Reviews Genetics 2009 10 7 431 442
5. Qiu J., Gao C. L., Zhang M., Chen R. H., Chi X., Liu F., Zhang C. M., Ji C. B., Chen X. H., Zhao Y. P., Li X. N., Tong M. L., Ni Y. H., Guo X. R., LYRM1, a novel gene promotes proliferation and inhibits apoptosis of preadipocytes European Journal of Endocrinology 2009 160 2 177 184
6. Qiu J., Ni Y. H., Gong H. X., Fei L., Pan X. Q., Guo M., Chen R. H., Guo X. R., Identification of differentially expressed genes in omental adipose tissues of obese patients by suppression subtractive hybridization Biochemical and Biophysical Research Communications 2007 352 2 469 478 (Pubitemid 44838510)
7. Cao X. G., Kou C. Z., Zhao Y. P., Gao C. L., Zhu C., Zhang C. M., Ji C. B., Qin D. N., Zhang M., Guo X. R., Overexpression of LYRM1 induces mitochondrial impairment in 3T3-L1 adipocytes Molecular Genetics and Metabolism 2010 101 4 395 399
8. Goossens G. H., The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance Physiology and Behavior 2008 94 2 206 218 (Pubitemid 351615418)
9. Maeda K., Uysal K. T., Makowski L., Grgn C. Z., Atsumi G., Parker R. A., Brning J., Hertzel A. V., Bernlohr D. A., Hotamisligil G. S., Role of the fatty acid binding protein mal1 in obesity and insulin resistance Diabetes 2003 52 2 300 307 (Pubitemid 36173182)
10. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 1993 259 5091 87 91 (Pubitemid 23036092)
11. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes Nature 2001 409 6818 307 312 (Pubitemid 32151228)
12. Wang P., Renes J., Bouwman F., Bunschoten A., Mariman E., Keijer J., Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression Diabetologia 2007 50 3 654 665 (Pubitemid 46215510)
13. Student A. K., Hsu R. Y., Lane M. D., Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes Journal of Biological Chemistry 1980 255 10 4745 4750 (Pubitemid 10060752)
14. Subauste A. R., Burant C. F., Role of FoxO1 in FFA-induced oxidative stress in adipocytes American Journal of Physiology 2007 293 1 E159 E164
15. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., Kopp A., Schoelmerich J., Falk W., Fatty acid-induced induction of Toll-like receptor-4/nuclear factor- B pathway in adipocytes links nutritional signalling with innate immunity Immunology 2009 126 2 233 245
16. Gregor M. F., Hotamisligil G. S., Inflammatory Mechanisms in Obesity Annual Review of Immunology 2011 29 415 445
17. Bergman R. N., Ader M., Free fatty acids and pathogenesis of type 2 diabetes mellitus Trends in Endocrinology and Metabolism 2000 11 9 351 356
18. Shepherd P. R., Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues Acta Physiologica Scandinavica 2005 183 1 3 12 (Pubitemid 40188032)
19. Lim J. H., Lee J. I., Suh Y. H., Kim W., Song J. H., Jung M. H., Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells Diabetologia 2006 49 8 1924 1936 (Pubitemid 44025048)
20. Yu C., Chen Y., Cline G. W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J. K., Cushman S. W., Cooney G. J., Atcheson B., White M. F., Kraegen E. W., Shulman G. I., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle Journal of Biological Chemistry 2002 277 52 50230 50236 (Pubitemid 36042170)
21. Gao Z., Zhang X., Zuberi A., Hwang D., Quon M. J., Lefevre M., Ye J., Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes Molecular Endocrinology 2004 18 8 2024 2034 (Pubitemid 39006506)
22. Uysal K. T., Wiesbrock S. M., Marino M. W., Hotamisligil G. S., Protection from obesity-induced insulin resistance in mice lacking TNF- alpha function Nature 1997 389 6651 610 614 (Pubitemid 27446179)
23. Dominguez H., Storgaard H., Rask-Madsen C., Hermann T. S., Ihlemann N., Nielsen D. B., Spohr C., Kober L., Vaag A., Torp-Pedersen C., Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes Journal of Vascular Research 2005 42 6 517 525 (Pubitemid 41527607)
24. Bernstein L. E., Berry J., Kim S., Canavan B., Grinspoon S. K., Effects of etanercept in patients with the metabolic syndrome Archives of Internal Medicine 2006 166 8 902 908
25. Rajala M. W., Qi Y., Patel H. R., Takahashi N., Banerjee R., Pajvani U. B., Sinha M. K., Gingerich R. L., Scherer P. E., Ahima R. S., Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting Diabetes 2004 53 7 1671 1679 (Pubitemid 38857023)
26. Rajala M. W., Obici S., Scherer P. E., Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production Journal of Clinical Investigation 2003 111 2 225 230 (Pubitemid 36105921)
27. Banerjee R. R., Rangwala S. M., Shapiro J. S., Rich A. S., Rhoades B., Qi Y., Wang J., Rajala M. W., Pocai A., Scherer P. E., Steppan C. M., Ahima R. S., Obici S., Rossetti L., Lazar M. A., Regulation of fasted blood glucose by resistin Science 2004 303 5661 1195 1198 (Pubitemid 38233585)
28. Rosen E. D., Hsu C. H., Wang X., Sakai S., Freeman M. W., Gonzalez F. J., Spiegelman B. M., C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway Genes and Development 2002 16 1 22 26 (Pubitemid 34049634)
29. Bays H., Mandarino L., DeFronzo R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach Journal of Clinical Endocrinology and Metabolism 2004 89 2 463 478 (Pubitemid 38269844)
30. Szalkowski D., White-Carrington S., Berger J., Zhang B., Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells Endocrinology 1995 136 4 1474 1481
31. Patel L., Buckels A. C., Kinghorn I. J., Murdock P. R., Holbrook J. D., Plumpton C., Macphee C. H., Smith S. A., Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochemical and Biophysical Research Communications 2003 300 2 472 476 (Pubitemid 38375833)
32. Lehrke M., Reilly M. P., Millington S. C., Iqbal N., Rader D. J., Lazar M. A., An inflammatory cascade leading to hyperresistinemia in humans PLoS Medicine 2004 1 2 e45
33. Jung H. S., Youn B. S., Cho Y. M., Yu K. Y., Park H. J., Shin C. S., Kim S. Y., Lee H. K., Park K. S., The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus Metabolism 2005 54 3 314 320 (Pubitemid 40250091)
34. Kamin D., Hadigan C., Lehrke M., Mazza S., Lazar M. A., Grinspoon S., Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone Journal of Clinical Endocrinology and Metabolism 2005 90 6 3423 3426 (Pubitemid 41014307)
35. Miyazaki Y., Glass L., Triplitt C., Matsuda M., Cusi K., Mahankali A., Mahankali S., Mandarino L. J., DeFronzo R. A., Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients Diabetologia 2001 44 12 2210 2219 (Pubitemid 34015474)
36. Kou C., Cao X., Qin D., Ji C., Zhu J., Zhang C., Zhu C., Gao C., Chen R., Guo X., Zhang M., Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3K (p85) and Akt Molecular and Cellular Biochemistry 2010 348 1-2 149 154